Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;97(8):E321-E324.
doi: 10.1002/ajh.26629. Epub 2022 Jun 24.

Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients

Marco Salvini  1 , Camilla Damonte  2 , Lorenzo Mortara  3 , Fabrizio Maggi  1   2 , Antonino Bruno  3   4 , Giacomo Pellegrini  1   5 , Barbara Mora  1   2 , Marco Brociner  1 , Alessia Ingrassia  1 , Roberta Mattarucchi  1 , Benedetta Bianchi  1 , Davide Sirocchi  1 , Stefania Agnoli  1 , Elisa Rumi  6   7 , Michele Merli  1 , Alessandro Fossati  1 , Susanna Bassi  1 , Raffaella Bombelli  3 , Matteo Gallazzi  3 , Oscar Borsani  7 , Andreina Baj  1   2 , Matteo Franchi  5   8 , Paolo A Grossi  1   2 , Francesco Passamonti  1   2
Affiliations

Immunogenicity and clinical efficacy of anti-SARS-CoV-2 vaccination in patients with hematological malignancies: Results of a prospective cohort study of 365 patients

Marco Salvini et al. Am J Hematol. 2022 Aug.
No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

FIGURE 1
FIGURE 1
Serology test results and SARS‐CoV‐2 breakthrough infections. Visual description of serology test results and distribution of breakthrough infections during follow‐up (A). Cumulative risk of SARS‐CoV‐2 breakthrough infection according to seroconversion status after vaccination (B). NEG, seronegative; POS, seropositive.
See this image and copyright information in PMC

References

    1. https://covid19.who.int/
    1. Passamonti F, Cattaneo C, Arcaini L, et al. Clinical characteristics and risk factors associated with COVID‐19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study. Lancet Haematol. 2020;7:737‐745. - PMC - PubMed
    1. https://www.iss.it/documents/20126/0/Flash_survey31dicembre.pdf/317a7725...
    1. https://www.iss.it/documents/20126/0/Report_flashVarianti_14gennaio22.pd...
    1. https://www.epicentro.iss.it/coronavirus/sars-cov-2-dashboard

Publication types

Substances